- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02559453
Outcomes for 2 Operations Versus ≥ 3 Operations in Infected Wounds
A Randomized Trial Comparing the Outcomes for 2 Operations Versus ≥ 3 Operations in Infected Wounds Requiring Hospitalization
Study Overview
Detailed Description
There is a lack of consensus about whether or not a patient with an infected wound requires more than 2 surgical procedures. For patients admitted for an infected wound this study will investigate whether 2, compared with ≥3, operative interventions results in better outcomes. All patients admitted for an infected wound will be assessed for eligibility in the study. If eligible, subjects will be randomized into Cohort A (2 operative visits) or Cohort B (≥3 operative visits). Subjects will then be followed during the hospitalization as well as 180 days post discharge.
A total of 250 subjects will be enrolled into this study. Two operations (n=125) will be compared with ≥3 operations (n=125) during the hospitalization. We will compare the following factors between the two treatment groups: length of hospital stay; readmission post-discharge; quality of life; proportion of wounds closed or covered with a graft; culture results; host factors; environmental factors post-hospital discharge; and, financial charges related to admission and readmission. We expect full enrollment to take 3 years in duration.
Debridement of the wound will be performed in the customary manner per SOC in the operating room. Prior to the start of the study, the surgeons performing the operations will be required to view a video that demonstrates the standardized debridement technique that will be utilized. The following is the standardized technique depicted in the video:
All wound surfaces will be painted with dye prior to debridement. Debridement involves the use of a scalpel, scissors, curette, rongeur, or hydro-surgery. A 2-3 millimeter skin edge around the perimeter of the wound will also be resected. All infected/nonviable tissue will be removed and all tissues with dye will be surgically removed. This includes decompression of any purulent material and excision of any indurated tissue (until tissue pliability is established). Nonviable tissue includes necrotic and fibrous tissue. Debridement will be performed until the there is bleeding on the wound base and perimeter.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Infected wound requiring hospital admission
- Infected wound requiring an operative intervention
- Wound can be located anywhere on the body
- Patient able and willing to comply with all study requirements
Exclusion Criteria:
- Planned free tissue flap for soft tissue reconstruction
- Wound located over exposed joint implant
- Wound located over exposed hardware
- Disease or treatment causing substantial immunosuppression
- History of collagen vascular disease
- Transplant recipient
- Venous stasis ulcer
- Radiation-induced ulcer
- Contraindication for use of negative pressure wound therapy with instillation of normal saline
- Unable or unwilling to comply with study requirements
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: 2 operations
Subjects in this arm will receive a maximum of two surgical debridements of their wound.
|
Removing dead tissue from infected wounds.
|
Active Comparator: 3 or more operations
Subjects in this arm will receive three or more surgical debridements of their wound.
|
Removing dead tissue from infected wounds.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Number of post-hospital discharge complications between subjects who received 2 versus 3 or more debridement operations prior to closure.
Time Frame: 180 Days
|
180 Days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Christopher Attinger, MD, MedStar Georgetown University Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 121012014
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Wound Infection
-
Pulmatrix Inc.TerminatedPost Operative Wound Infection | Postoperative Wound Infection-deepUnited States
-
Carilion ClinicSmith & Nephew, Inc.; DeRoyal Industries, Inc.CompletedImpaired Wound Healing | Postoperative Wound Infection-deepUnited States
-
PolyPid Ltd.CompletedPostoperative Wound Infection Superficial Incisional | Postoperative Wound Infection Deep Incisional Surgical SiteIsrael
-
Children's Healthcare of AtlantaWithdrawnPostoperative Wound InfectionUnited States
-
HITEC-Institute of Medical SciencesCompletedWound Infection | Wound Dehiscence | Wound Surgical | Wound BleedingPakistan
-
Universitat Internacional de CatalunyaHospital de GranollersCompletedSurgical Wound Infection | Postoperative Wound Infection | Postoperative Wound Infection Superficial Incisional | Preventive TherapySpain
-
Military Medical AcademyRecruitingPostoperative Wound Infection Superficial Incisional | Postoperative Wound Infection Deep Incisional Surgical SiteBulgaria
-
PfizerCompletedSurgical Wound Infection | Postoperative Wound Infection
-
Hospital for Special Surgery, New YorkNew York Presbyterian HospitalRecruitingSurgical Wound | Post Operative Wound InfectionUnited States
-
Brentwood Biomedical Research InstituteCompletedPostoperative Wound Infection | Traumatic Wound Infection | Closed Soft Tissue AbscessUnited States
Clinical Trials on Debridement
-
Smith & Nephew, Inc.TerminatedTorn MeniscusUnited States
-
Medaxis, LLCNAMSARecruitingDiabetic Foot Ulcer | Venous Leg Ulcer | Surgical Wound Dehiscence | Traumatic WoundsUnited States
-
Hospital for Special Surgery, New YorkTerminated
-
North Florida Foundation for Research and EducationNorth Florida/South Georgia Veterans Health System; BiomondeCompletedBacterial Infection | Lower Extremity or Diabetic Foot UlcersUnited States
-
National Taiwan University HospitalUnknown
-
University of MichiganMorita J USACompleted
-
Scil Technology GmbHFGK Clinical Research GmbHUnknownPeriodontal Bone Loss | Alveolar Bone LossHungary
-
Ain Shams UniversityNot yet recruitingPeriodontal Diseases
-
St. Paul's Hospital, CanadaUnknown
-
Southwest Regional Wound Care CenterWithdrawn